A randomized, double-blind and cross-over trial to examine effects of continuous administration of intranasal oxytocin on social dysfunction in subjects with autism spectrum disorders
Phase 2
- Conditions
- Autism spectrum disorders
- Registration Number
- JPRN-UMIN000007122
- Lead Sponsor
- Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of allergy for oxytocin 2) History of seizures or traumatic brain injury with any known cognitive consequences or loss of consciousness for more than five minutes 3) History of substance abuse or addiction 4) Current instability of comorbid psychiatric symptoms 5) Having contraindication of MR-scanning
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method